The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome

Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes, hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic cardiovascular diseases. These conditions frequently require multiple medications, raising the risk of polypharmacy, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultana, Rizwana, Sissoho, Fatoumatta, Kaushik, Vinod P., Raji, Mukaila A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410036/
https://www.ncbi.nlm.nih.gov/pubmed/36013401
http://dx.doi.org/10.3390/life12081222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410036/
https://www.ncbi.nlm.nih.gov/pubmed/36013401
http://dx.doi.org/10.3390/life12081222

Ejemplares similares